System analysis based on the cancer–immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma
Background Immune checkpoint inhibitors as monotherapies for advanced hepatocellular carcinoma (HCC) fail to achieve satisfying results, while combination therapies show greater efficacy. Therefore, identifying new combined targets for immune checkpoint inhibitors could be promising.Methods We combi...
Main Authors: | Yu Wang, Yong Yang, Xu Wang, Xinying Tang, Tao Zhou, Haoyu Wang, Xingyi Chen, Yushi Ding, Haoyang Tu, Shengyang Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-03-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/3/e004414.full |
Similar Items
-
ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma
by: Qingfang Zhao, et al.
Published: (2023-10-01) -
Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma
by: Zhang X, et al.
Published: (2023-04-01) -
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334
by: Dapeng Sun, et al.
Published: (2022-05-01) -
<i>ZNF385A</i> and <i>ZNF346</i> Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
by: Qihang Peng, et al.
Published: (2023-02-01) -
Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma
by: Bao-Wen Tian, et al.
Published: (2022-08-01)